This page includes the latest FDA filings for Swedish Orphan Biovitrum Ab Publ Sweden. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
Device Company | Device | Date |
|---|---|---|
| Swedish Orphan Biovitrum AB (publ), Boehringer Ingelheim Pharma GmbH & Co KG (BIP, an affiliate to BI RCV), Germany, Boehringer Ingelheim RCV, Austria, Charles River Laboratories Edinburgh Ltd., UK, Charles River Laboratories Inc. USA, Eurofins Biolab S.r.l., I | Prescription Medication | 2024-11-15 |
| Swedish Orphan Biovitrum AB (publ), Boehringer Ingelheim Pharma GmbH & Co KG (BIP, an affiliate to BI RCV), Germany, Boehringer Ingelheim RCV, Austria, Charles River Laboratories Edinburgh Ltd., UK, Charles River Laboratories Inc. USA, Eurofins Biolab S.r.l., I | Prescription Medication | 2020-12-30 |
| Swedish Orphan Biovitrum AB (publ), Boehringer Ingelheim Pharma GmbH & Co KG (BIP, an affiliate to BI RCV), Germany, Boehringer Ingelheim RCV, Austria, Charles River Laboratories Edinburgh Ltd., UK, Charles River Laboratories Inc. USA, Eurofins Biolab S.r.l., I | Prescription Medication | 2018-08-07 |